Mettler-Toledo International Inc. (MTD)

Mettler-Toledo International Inc. (MTD) is a healthcare company (diagnostics & research) based in Switzerland. The share price is $1,722.67, down 0.27% on the day, which values the company at $34.26B. Price as of 17 Nov 2026, 17:23 UTC, from Yahoo Finance.

Key facts

Share price
$1,722.67−0.27% today
Market value
$34.26B
P/E ratio
37.4×last 12 months
Forward P/E
32.4×
Funk Score
54/100
Against its own history
Well above its usual priceusual price $1,255.21
200-week average
$1,309.4632% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Mettler-Toledo International Inc. in more detail

MTD trades at 37.4× its last twelve months' earnings, 32.4× next year's expected earnings, 8.2× sales. Measured against its own history, the price is 37% above what its usual multiples would imply ($1,255.21) — well above its usual price. It sits 32% above its 200-week average of $1,309.46.

Over the last five fiscal years Mettler-Toledo International Inc. has compounded revenue 5.5% a year, earnings per share 11.0% a year, free cash flow 6.1% a year. Its Funk Score is 54 out of 100 (financial strength 6.8, profitability 8.6, growth 4.5, value 1.7, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling.

3 of the superinvestors tracked here hold MTD, including Ron Baron (0.3% of the portfolio), Wallace Weitz (0.3% of the portfolio), Steve Cohen (0.3% of the portfolio).

Superinvestors holding MTD

3 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:MTD vs ALC (Mettler-Toledo International Inc. vs Alcon)MTD vs CNC (Mettler-Toledo International Inc. vs Centene)MTD vs GMAB (Mettler-Toledo International Inc. vs Genmab)MTD vs ILMN (Mettler-Toledo International Inc. vs Illumina)MTD vs RMD (Mettler-Toledo International Inc. vs ResMed)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Mettler-Toledo International Inc. (MTD): questions and answers

What is MTD's P/E ratio?

Mettler-Toledo International Inc. trades at 37.4× its last twelve months' earnings and 32.4× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 11.6× to 51.8×, with a median of 28.9×.

What is MTD's PEG ratio?

Mettler-Toledo International Inc.'s PEG ratio is 3.23 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Mettler-Toledo International Inc.'s market cap?

Mettler-Toledo International Inc. is valued at $34.26B at a share price of $1,722.67.

Is MTD overvalued or undervalued?

Against its own history, MTD is well above its usual price: the price is 37% above the $1,255.21 implied by the median multiples it has traded at (price / earnings, price / sales, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is MTD above its 200-week moving average?

Yes. MTD is 31.6% above its 200-week average of $1,309.46. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Mettler-Toledo International Inc. growing?

Over the last five fiscal years Mettler-Toledo International Inc.'s revenue grew 5.5% a year and its earnings per share 11.0% a year; over ten years revenue grew 5.3% a year.

Cite this page

Funkfolio, “Mettler-Toledo International Inc. (MTD) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/MTD

Underlying data: Yahoo Finance; company filings with the SEC.